Preoperative neoadjuvant chemoimmunotherapy for locally advanced head and neck squamous cell carcinoma patients: A prospective, single-arm, phase II clinical study

被引：0
|
作者：
Han, P. [1 ]
Huang, X. [1 ]
Liang, F. [1 ]
Lin, P. [1 ]
Chen, R. [1 ]
Wu, T. [1 ]
Li, Y. [1 ]
机构：
[1] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Otorhinolaryngol Head & Neck Surg, Guangzhou, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.08.920
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
858P
引用
收藏
页码：S619 / S619
页数：1
相关论文
共 50 条
  • [1] Neoadjuvant Chemoimmunotherapy for the Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma: A Single-Arm Phase 2 Clinical Trial
    Zhang, Zhanjie
    Wu, Bian
    Peng, Gang
    Xiao, Guixiang
    Huang, Jing
    Ding, Qian
    Yang, Chengzhang
    Xiong, Xingao
    Ma, Hui
    Shi, Liangliang
    Yang, Jinsong
    Hong, Xiaohua
    Wei, Jielin
    Qin, You
    Wan, Chao
    Zhong, Yi
    Zhou, Yan
    Zhao, Xueyan
    Leng, Yangming
    Zhang, Tao
    Wu, Gang
    Yao, Min
    Zhang, Xiaomeng
    Yang, Kunyu
    CLINICAL CANCER RESEARCH, 2022, 28 (15) : 3268 - 3276
  • [2] Neoadjuvant tislelizumab combined with APF for patients with locally advanced head and neck squamous cell carcinoma: A prospective single-arm clinical trial
    Yan, Jing
    Wang, Kong-cheng
    Yang, Mi
    Gu, Ya-Jun
    Huang, Bin
    Zhu, Yahui
    Sha, Hui-zi
    Zhu, Jing
    Zhu, Chan
    Chen, Dong-sheng
    Qian, Xiao-Yun
    Shen, Xiao-hui
    Chen, Hong
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [3] Neoadjuvant pembrolizumab/nab-paclitaxel/cisplatin in patients with locally advanced head and neck squamous cell carcinoma: A single-arm phase II study
    Zhang, Siyi
    Ma, Haiqing
    Zhan, Jiandong
    Zhu, Lijun
    Zhang, Hong-Dan
    Du, Shasha
    Dong, Qiumei
    Wang, Guangyi
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [4] Neoadjuvant chemoimmunotherapy for the treatment of locally advanced laryngeal and hypopharyngeal squamous cell carcinoma: A single-arm phase 2 clinical trial.
    Chen, Yanfeng
    Yang, Ankui
    Mao, Yan-Ping
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [5] Pembrolizumab in combination with low-dose cisplatin/5-fluorouracil for neoadjuvant chemoimmunotherapy of locally advanced head and neck squamous cell carcinoma: A single-arm clinical trial
    Xu, J.
    Zhang, Y.
    Shao, C.
    Chen, K.
    Guo, H.
    Jiang, H.
    Bi, A.
    Lu, D.
    Wang, J.
    Jiang, L.
    Ru, G.
    He, X.
    Wang, Z.
    Wang, L.
    Zheng, G.
    Huang, P.
    Duan, Y.
    Tan, Z.
    Zheng, C.
    Ge, M.
    ANNALS OF ONCOLOGY, 2024, 35 : S620 - S620
  • [6] Camrelizumab plus apatinib as induction therapy for locally advanced head and neck squamous cell carcinoma (IMplus): A single-arm phase II study.
    Ye, Lulu
    Zhang, Lin
    Li, Rongrong
    Dou, Shengjin
    Jiang, Wen
    Zhu, Guopei
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [7] Safety and efficacy of neoadjuvant therapy with tislelizumab plus chemotherapy for locally advanced head and neck squamous cell carcinoma: a single-arm, retrospective study
    Liang, Haifeng
    Liang, Wenting
    Tian, Jiawang
    Zheng, Shibei
    Su, Yangzhou
    Huang, Piao
    Chen, Renhui
    Guan, Zhong
    Cai, Qian
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2025, 74 (03)
  • [8] Single-arm phase II study of multiagent concurrent chemoradiotherapy and gefitinib in locoregionally advanced squamous cell carcinoma of the head and neck
    Rodriguez, Cristina P.
    Adelstein, David J.
    Rybicki, Lisa A.
    Saxton, Jerrold P.
    Lorenz, Robert R.
    Wood, Benjamin G.
    Scharpf, Joseph
    Ives, Denise I.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2012, 34 (11): : 1517 - 1523
  • [9] Final analysis of a phase II trial of neoadjuvant chemoimmunotherapy for locoregionally advanced head and neck squamous cell carcinoma
    Zhao, Xueyan
    Zhou, Yan
    Peng, Gang
    Wen, Lu
    Hong, Xiaohua
    Hu, Yuan
    Wu, Bian
    Liu, Xixi
    Zhang, Zhanjie
    Xiao, Guixiang
    Huang, Jing
    Ding, Qian
    Yang, Chengzhang
    Xiong, Xingao
    Ma, Hui
    Shi, Liangliang
    Yang, Jinsong
    Wei, Jielin
    Qin, You
    Wan, Chao
    Zhong, Yi
    Leng, Yangming
    Zhang, Tao
    Wu, Gang
    Yao, Min
    Jia, Yulin
    Zhang, Xiaomeng
    Yang, Kunyu
    ORAL ONCOLOGY, 2024, 156
  • [10] Neoadjuvant tislelizumab with afatinib for locally advanced head and neck squamous cell carcinoma (neoCHANCE-1): An open-label, single-arm, phase 2 study
    Wei, Zhigong
    Chen, Huijiao
    Cai, Lei
    Chen, Fei
    Liu, Jun
    Peng, Xingchen
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345